Abstract
One of the most important antioxidant enzymes is superoxide dismutase (SOD), which catalyzes the dismutation of superoxide radicals to peroxide. The gene for CuZnSOD lies in humans on chromosome 21, and its activity is increased in patients with Down syndrome. However, instead of being beneficial, increased lipid peroxidation is associated with this increased expression, and also studies on bacteria and transgenic animals show that high levels of SOD actually lead to increased lipid peroxidation and hypersensitivity to oxidative stress. Using mathematical models, we investigated the question of how overexpression of SOD can lead to increased oxidative stress, although it is an antioxidant enzyme. We considered several possibilities that have been proposed in the literature, such as CuZnSOD-catalyzed hydroxyl radical formation, superoxide-mediated inhibition of membrane peroxidation, and short-circuiting of the Cu(I)ZnSOD/Cu(II)ZnSOD redox cycle. We found that one of the proposed mechanisms under certain circumstances is able to explain the increased oxidative stress caused by SOD. Furthermore, we identified an additional mechanism that agrees well with experimental observations. We call it the "alternative pathway" mechanism, b...Continue Reading
References
Feb 1, 1991·Molecular and Cellular Biology·I ReveillaudJ E Fleming
Jan 1, 1982·Annals of the New York Academy of Sciences·P M Sinet
Sep 1, 1984·Brain Research·B W Brooksbank, R Balazs
Feb 1, 1994·Free Radical Biology & Medicine·S K NelsonJ M McCord
Feb 15, 1993·Archives of Biochemistry and Biophysics·W C Orr, R S Sohal
Sep 27, 2000·The Journal of Biological Chemistry·S I Liochev, I Fridovich
Citations
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D SatgéM-O Réthoré
Apr 29, 2008·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Sataro Goto
Jan 15, 2005·Free Radical Biology & Medicine·Tsuyoshi EndoJuichi Ito
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maureen M O'BrienUNKNOWN Children's Oncology Group Study POG 9421
Feb 7, 2012·Trends in Endocrinology and Metabolism : TEM·Kelsey H Fisher-Wellman, P Darrell Neufer
Dec 6, 2011·Pharmacology & Therapeutics·Koen RaedscheldersDavid D Y Chen
Nov 6, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andre StrydomZuzana Walker
Nov 11, 2005·The EMBO Journal·José P SilvaNils-Göran Larsson
May 30, 2012·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Thomas B L Kirkwood, Axel Kowald
Apr 12, 2016·Frontiers in Pharmacology·Nadiah AbuNoorjahan B Alitheen
Jan 8, 2013·Ophthalmic Genetics·Dragana CelojevicMadeleine Zetterberg
Jun 17, 2015·Biomarkers in Medicine·Elvin ZenginChristoph Bickel
Jun 21, 2008·Orvosi hetilap·Petra VargaEva Oláh
Mar 28, 2012·Mechanisms of Ageing and Development·Axel KowaldHeinz D Osiewacz
Sep 15, 2015·PloS One·Chandrasekaran KomalapriyaM Carmen Romano
Oct 19, 2017·Biomarkers in Medicine·Christoph SinningPeter Clemmensen
Jul 22, 2006·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Ordonez Francisco JavierRosety-Rodriguez Manuel
Oct 3, 2007·Mental Retardation and Developmental Disabilities Research Reviews·Warren B Zigman, Ira T Lott